| Proteome Science | |
| Improved protein arrays for quantitative systems analysis of the dynamics of signaling pathway interactions | |
| Chin-Rang Yang3  David A Boothman4  Minzi Ruan5  Amyn A Habib2  Makoto Kuro-o1  Johanne Pastor1  Yonglong Zou4  Ameena J Jiwani2  Ying Dong4  Xiaoyu Wang3  | |
| [1] Department of Pathology, University of Texas Southwestern Medical Center at Dallas, Dallas, TX 75390, USA;North Texas VA Healthcare System, Dallas, TX 75216, USA;Department of Radiation Oncology, University of Texas Southwestern Medical Center at Dallas, Dallas, TX 75390, USA;Department of Pharmacology, University of Texas Southwestern Medical Center at Dallas, Dallas, TX 75390, USA;VigeneTech, Inc. Carlisle, MA 01741, USA | |
| 关键词: systems biology; glioma; image analysis; cross-talk; signaling pathway; quantitative analysis; quantum dot; protein array; | |
| Others : 821026 DOI : 10.1186/1477-5956-9-53 |
|
| received in 2011-04-21, accepted in 2011-09-15, 发布年份 2011 | |
PDF
|
|
【 摘 要 】
An improved version of quantitative protein array platform utilizing linear Quantum dot signaling for systematically measuring protein levels and phosphorylation states is presented. The signals are amplified linearly by a confocal laser Quantum dot scanner resulting in ~1000-fold more sensitivity than traditional Western blots, but are not linear by the enzyme-based amplification. Software is developed to facilitate the quantitative readouts of signaling network activities. Kinetics of EGFRvIII mutant signaling was analyzed to quantify cross-talks between EGFR and other signaling pathways.
【 授权许可】
2011 Wang et al; licensee BioMed Central Ltd.
【 预 览 】
| Files | Size | Format | View |
|---|---|---|---|
| 20140712062906108.pdf | 3034KB | ||
| Figure 10. | 101KB | Image | |
| Figure 9. | 126KB | Image | |
| Figure 8. | 137KB | Image | |
| Figure 7. | 277KB | Image | |
| Figure 6. | 50KB | Image | |
| Figure 5. | 82KB | Image | |
| Figure 4. | 19KB | Image | |
| Figure 3. | 59KB | Image | |
| Figure 2. | 63KB | Image | |
| Figure 1. | 58KB | Image |
【 图 表 】
Figure 1.
Figure 2.
Figure 3.
Figure 4.
Figure 5.
Figure 6.
Figure 7.
Figure 8.
Figure 9.
Figure 10.
【 参考文献 】
- [1]Liotta LA, Espina V, Mehta AI, Calvert V, Rosenblatt K, Geho D, Munson PJ, Young L, Wulfkuhle J, Petricoin EF: Protein microarrays: meeting analytical challenges for clinical applications. Cancer Cell 2003, 3:317-325.
- [2]Spurrier B, Ramalingam S, Nishizuka S: Reverse-phase protein lysate microarrays for cell signaling analysis. Nat Protoc 2008, 3:1796-1808.
- [3]Kornblau SM, Tibes R, Qiu YH, Chen W, Kantarjian HM, Andreeff M, Coombes KR, Mills GB: Functional proteomic profiling of AML predicts response and survival. Blood 2009, 113:154-164.
- [4]Brase JC, Mannsperger H, Frohlich H, Gade S, Schmidt C, Wiemann S, Beissbarth T, Schlomm T, Sultmann H, Korf U: Increasing the sensitivity of reverse phase protein arrays by antibody-mediated signal amplification. Proteome Sci 8:36.
- [5]Shingyoji M, Gerion D, Pinkel D, Gray JW, Chen F: Quantum dots-based reverse phase protein microarray. Talanta 2005, 67:472-478.
- [6]Geho D, Lahar N, Gurnani P, Huebschman M, Herrmann P, Espina V, Shi A, Wulfkuhle J, Garner H, Petricoin E, et al.: Pegylated, steptavidin-conjugated quantum dots are effective detection elements for reverse-phase protein microarrays. Bioconjug Chem 2005, 16:559-566.
- [7]Sheehan KM, Calvert VS, Kay EW, Lu Y, Fishman D, Espina V, Aquino J, Speer R, Araujo R, Mills GB, et al.: Use of reverse phase protein microarrays and reference standard development for molecular network analysis of metastatic ovarian carcinoma. Mol Cell Proteomics 2005, 4:346-355.
- [8]Sheehan KM, Gulmann C, Eichler GS, Weinstein JN, Barrett HL, Kay EW, Conroy RM, Liotta LA, Petricoin EF: Signal pathway profiling of epithelial and stromal compartments of colonic carcinoma reveals epithelial-mesenchymal transition. Oncogene 2008, 27:323-331.
- [9]VanMeter AJ, Rodriguez AS, Bowman ED, Jen J, Harris CC, Deng J, Calvert VS, Silvestri A, Fredolini C, Chandhoke V, et al.: Laser capture microdissection and protein microarray analysis of human non-small cell lung cancer: differential epidermal growth factor receptor (EGPR) phosphorylation events associated with mutated EGFR compared with wild type. Mol Cell Proteomics 2008, 7:1902-1924.
- [10]Wulfkuhle JD, Aquino JA, Calvert VS, Fishman DA, Coukos G, Liotta LA, Petricoin EF: Signal pathway profiling of ovarian cancer from human tissue specimens using reverse-phase protein microarrays. Proteomics 2003, 3:2085-2090.
- [11]Loebke C, Sueltmann H, Schmidt C, Henjes F, Wiemann S, Poustka A, Korf U: Infrared-based protein detection arrays for quantitative proteomics. Proteomics 2007, 7:558-564.
- [12]Hatanpaa KJ, Burma S, Zhao D, Habib AA: Epidermal growth factor receptor in glioma: signal transduction, neuropathology, imaging, and radioresistance. Neoplasia 2010, 12:675-684.
- [13]Ruan M: Protein Microarray Image Analysis. In Functional Protein Microarrays in Drug Discovery. 1st edition. Edited by Predki PF. CRC Press; 2006:359.
- [14]Hu J, He X, Baggerly KA, Coombes KR, Hennessy BT, Mills GB: Non-parametric quantification of protein lysate arrays. Bioinformatics 2007, 23:1986-1994.
- [15]Li L, Dutra A, Pak E, Labrie JE, Gerstein RM, Pandolfi PP, Recht LD, Ross AH: EGFRvIII expression and PTEN loss synergistically induce chromosomal instability and glial tumors. Neuro Oncol 2009, 11:9-21.
- [16]C VS, Babar SM, Song EJ, Oh E, Yoo YS: Kinetic analysis of the MAPK and PI3K/Akt signaling pathways. Mol Cells 2008, 25:397-406.
- [17]Andersen P, Villingshoj M, Poulsen HS, Stockhausen MT: Improved response by co-targeting EGFR/EGFRvIII and Src family kinases in human cancer cells. Cancer Invest 2009, 27:178-183.
- [18]Bromann PA, Korkaya H, Courtneidge SA: The interplay between Src family kinases and receptor tyrosine kinases. Oncogene 2004, 23:7957-7968.
- [19]Antonyak MA, Kenyon LC, Godwin AK, James DC, Emlet DR, Okamoto I, Tnani M, Holgado-Madruga M, Moscatello DK, Wong AJ: Elevated JNK activation contributes to the pathogenesis of human brain tumors. Oncogene 2002, 21:5038-5046.
- [20]Antonyak MA, Moscatello DK, Wong AJ: Constitutive activation of c-Jun N-terminal kinase by a mutant epidermal growth factor receptor. J Biol Chem 1998, 273:2817-2822.
- [21]Aikin R, Maysinger D, Rosenberg L: Cross-talk between phosphatidylinositol 3-kinase/AKT and c-jun NH2-terminal kinase mediates survival of isolated human islets. Endocrinology 2004, 145:4522-4531.
- [22]Ramnarain DB, Park S, Lee DY, Hatanpaa KJ, Scoggin SO, Otu H, Libermann TA, Raisanen JM, Ashfaq R, Wong ET, et al.: Differential gene expression analysis reveals generation of an autocrine loop by a mutant epidermal growth factor receptor in glioma cells. Cancer Res 2006, 66:867-874.
PDF